A 5-year summary of real-life dietary egg consumption after completion of a 4-year egg powder oral immunotherapy (eOIT) protocol
Year: 2019
Type: article
Institutions: University of North Carolina at Chapel Hill, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Johns Hopkins University, Icahn School of Medicine at Mount Sinai, National Jewish Health, Emmes (United States), National Institutes of Health, National Institute of Allergy and Infectious Diseases
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Astellas Pharma US, Sanofi, Food Allergy Research and Education, Icahn School of Medicine at Mount Sinai, Johns Hopkins University, University of Arkansas for Medical Sciences, Regeneron Pharmaceuticals, Immune Tolerance Network, Aimmune Therapeutics, National Institutes of Health, Genentech, University of Colorado Denver, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1092703474, G1177608485, G1381991374, Immunobiology of Food Allergy and Its Treatment, G2356429518, G3629514564, UNC Clinical and Translational Science Award, G475936976, Expanding Translational Research in Arkansas, North Carolina Translational and Clinical Science Institute (NC TraCS), G748865769, G7561814170, G7592280020, Institute for Clinical and Translational Research, Mount Sinai Institutes for Clinical and Translational Sciences, University of North Carolina Food Allergy Initiative, Colorado Clinical and Translational Science Institute (UL1)
OpenAlex ID: W2914380249